These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 420817)

  • 1. Conformational changes accompanying the binding of antithrombin III to thrombin.
    Villanueva G; Danishefsky I
    Biochemistry; 1979 Mar; 18(5):810-7. PubMed ID: 420817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The oligosaccharide side chain on Asn-135 of alpha-antithrombin, absent in beta-antithrombin, decreases the heparin affinity of the inhibitor by affecting the heparin-induced conformational change.
    Turk B; Brieditis I; Bock SC; Olson ST; Björk I
    Biochemistry; 1997 Jun; 36(22):6682-91. PubMed ID: 9184148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circular dichroism spectroscopy of heparin-antithrombin interactions.
    Stone AL; Beeler D; Oosta G; Rosenberg RD
    Proc Natl Acad Sci U S A; 1982 Dec; 79(23):7190-4. PubMed ID: 6961402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tryptophan 60-D in the B-insertion loop of thrombin modulates the thrombin-antithrombin reaction.
    Rezaie AR
    Biochemistry; 1996 Feb; 35(6):1918-24. PubMed ID: 8639675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antithrombin conformation and the catalytic role of heparin. II. Is the heparin-induced conformational change in antithrombin required for rapid inactivation of thrombin?
    Peterson CB; Blackburn MN
    J Biol Chem; 1987 Jun; 262(16):7559-66. PubMed ID: 3584127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conformational differences between high clotting human alpha-thrombin and nonclotting gamma-thrombin.
    Villanueva GB
    Biochemistry; 1981 Nov; 20(23):6519-25. PubMed ID: 7306521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium inhibits the heparin-catalyzed antithrombin III/thrombin reaction by decreasing the apparent binding affinity of heparin for thrombin.
    Speight MO; Griffith MJ
    Arch Biochem Biophys; 1983 Sep; 225(2):958-63. PubMed ID: 6625618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Action of heparin on thrombin-antithrombin reaction.
    Machovich R; Blaskó G; Pálos LA
    Biochim Biophys Acta; 1975 Jan; 379(1):193-200. PubMed ID: 1115795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictions of the secondary structure of antithrombin III and the location of the heparin-binding site.
    Villanueva GB
    J Biol Chem; 1984 Feb; 259(4):2531-6. PubMed ID: 6698980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombin-induced proteolysis of human antithrombin III: an outstanding contribution of heparin.
    Marciniak E
    Br J Haematol; 1981 Jun; 48(2):325-36. PubMed ID: 7236529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catalytic and regulatory functions of N-bromosuccinimide-modified bovine thrombin.
    Pal PK; Starr T; Gertler MM
    Thromb Res; 1984 Nov; 36(4):293-303. PubMed ID: 6523442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Refolding properties of antithrombin III. Mechanism of binding to heparin.
    Villanueva GB; Allen N
    J Biol Chem; 1983 Nov; 258(22):14048-53. PubMed ID: 6643466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tryptophan residue at the heparin binding site in antithrombin III.
    Villaneuva GB; Perret V; Danishefsky I
    Arch Biochem Biophys; 1980 Aug; 203(1):453-7. PubMed ID: 7406509
    [No Abstract]   [Full Text] [Related]  

  • 14. The heparin-enhanced antithrombin III/thrombin reaction is saturable with respect to both thrombin and antithrombin III.
    Griffith MJ
    J Biol Chem; 1982 Dec; 257(23):13899-302. PubMed ID: 7142182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The allosteric mechanism of activation of antithrombin as an inhibitor of factor IXa and factor Xa: heparin-independent full activation through mutations adjacent to helix D.
    Dementiev A; Swanson R; Roth R; Isetti G; Izaguirre G; Olson ST; Gettins PGW
    J Biol Chem; 2013 Nov; 288(47):33611-33619. PubMed ID: 24068708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Properties of antithrombin-thrombin complex formed in the presence and in the absence of heparin.
    Danielsson A; Björk I
    Biochem J; 1983 Aug; 213(2):345-53. PubMed ID: 6615439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular weight analysis of antithrombin III-heparin and antithrombin III-thrombin-heparin complexes.
    Pletcher CH; Cunningham MT; Nelsestuen GL
    J Biol Chem; 1986 Mar; 261(9):4143-7. PubMed ID: 3949807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Properties of thrombin- and elastase-modified human antithrombin III.
    Gettins P; Harten B
    Biochemistry; 1988 May; 27(10):3634-9. PubMed ID: 3408716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-function relationships in heparin cofactor II: chemical modification of arginine and tryptophan and demonstration of a two-domain structure.
    Church FC; Villanueva GB; Griffith MJ
    Arch Biochem Biophys; 1986 Apr; 246(1):175-84. PubMed ID: 3754413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidation of human alpha-thrombin by the myeloperoxidase-H2O2-chloride system: structural and functional effects.
    De Cristofaro R; Landolfi R
    Thromb Haemost; 2000 Feb; 83(2):253-61. PubMed ID: 10739383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.